Parkinson's Disease (PD)
95
35
40
29
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
17 trials with published results (18%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
1.1%
1 terminated out of 95 trials
96.7%
+10.2% vs benchmark
12%
11 trials in Phase 3/4
59%
17 of 29 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 29 completed trials
Clinical Trials (95)
Closed-loop TMS for Tremor
Impact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's Disease
Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease
Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
A Study of Buntanetap in Participants With PD
Movement State-dependent Adaptive DBS for PD
A Study of NE3107 in Early Parkinson's
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease
Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease
Clinical Study of Chemogenetic Gene Therapy With AAV for Parkinson's Disease Using Stereotactic Surgery in the Subthalamic Nucleus
Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning Surgery
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
Effects of Cognitive Dual-Task on Gait in Parkinson's Disease
Neuroimaging of Parkinson's
A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease
Electrophysiology-based DBS Programming for PD
Observational Study Evaluating Robotic Spinal Mobilization in 16 Parkinson's Disease Participants. The Study Recorded Changes in Mobility, Sit-to-stand Performance, and Pain Scores After a 2-week Intervention With the BackHug Device.